Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
6. References
Anton, B., Fein, J., To, T., Li, X., Silberstein, L., and Evans, C.J., 1996, Immunohistochemical localization of ORL-1 in the central nervous system of the rat, J. Comp. Neurol. 367:1–23.
Albin, R.A., Young, A.B., and Penney, B., 1989, The functional anatomy of the basal ganglia disorders, Trends Neurosci. 12:366–375.
Alexander, G.E., and Crutcher, M.D., 1990, Functional architecture of basal ganglia circuits: neural substrates of parallel processing, Trends Neurosci. 13:266–271.
Bata-Garcia, J.L., H-Lopez, F.J., A-Cervera, F.J., A-Sandoval G and G-Alfaro JL., 2002, Circling behaviour induced by injection of serotonin reuptake inhibitors in the substantia nigra, Pharmacol. Biochem. Behavior 71:361–371.
Bergquist, F., Shahabi, H.N., Nissbrandt, H., 2003, Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod, Brain Res 973:81–91.
Blakley, G.G., Pohorecky, L.A., Benjamin, D., 2004, Behavioral and endocrine changes following antisense oligonucleotide-induced reduction in the rat NOP receptor, Psychopharmacology 171:421–428.
Blandini, F., and Greenamiry, J.T., 1998, Prospects of glutamate antagonists in the therapy of Parkinson’s disease, Fundam. Clin. Pharmacol. 12:4–12.
Boom, A., Mollereau, C., Meunier, J.C., Vassart, G., Parmentier, M., Vanderhaeghen, J.J., Schiffmann, S.N., 1999, Distribution of the nociceptin and nocistatin precursor transcript in the mouse central nervous system, Neuroscience 91:991–1007.
Bunzow, J.R., Saez, C., Mortrud, M., Bouvier, C., Williams, J.T., Low, M., and Grandy, D.K., 1994, Molecolar cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS lett. 347:284–288.
Calò, G., Guerrini, R., Rizzi, A., Salvadori, S., Regoli, D., 2000, Pharmacology of nociceptin and its receptor: a novel therapeutic target, Br. J. Pharmacol. 129:1261–1283.
Calò, G., Rizzi, A., Rizzi, D., Bigoni, R., Guerrini, R., Marzola, G., Marti, M., McDonald, J., Morari, M., Lambert, D.G., Salvadori, S., Regoli, D., 2002, [Nphe1,Arg14,Lys15]Nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor, Br. J. Pharmacol. 136:303–311.
Candeletti, S., and Ferri, S., 2000, Effects of an antisense oligonucleotide to pronociceptin and long-term prevention of morphine actions by nociceptin, Peptides 21:1119–1124.
Carter, C.J., 1982, Topographical distribution of possible glutamatergic pathways from the prefrontal cortex to the striatum and substantia nigra of the rat. Neuropharmacol. 21:379–383.
Chu, X., Xu, N., Li, P., and Wang, J.Q., 1999, The nociceptin receptor-mediated inhibition of the rat rostral ventrolateral medulla neurons in vitro, Eur. J. Pharmacol. 364:49–53.
Cox, B.M., Chavkin, C., Christie, M.J., Civelli, O., Evans, C., Hamon, M.D., Hoellt, V., Kieffer, B., Kitchen, I., Mcknight, A.T., Meunier, J.C., Portoghese, P.S., 2000, Opioid Receptors. In: The IUPHAR Compendium of Receptor Characterization and Classification. (Girdlestone D ed): IUPHAR Media Ltd, London.
Crespi, F., Martin, K.F., and Marsden, C.A., 1988, Measurement of extracellular basal levels of serotonin in vivo using nafion-coated carbon fibre electrodes combined with differential pulse voltammetry, Neuroscience. 27:885–896.
Darland, T., Heinricher, M.M., and Grandy, D.Y., 1998, Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more, Trends Neurosci., 21:215–221.
Devine, D.P., Taylor, L., Reinscheid, R.K., Monsma, F.J. Jr, Civelli, O., Akil, H., 1996a, Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ, Neurochem. Res. 21:1387–1396.
Devine, D.P., Reinscheid, R.K., Monsma, F.J. Jr, Civelli, O., Akil, H., 1996b, The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion, Brain Res. 727:225–229.
Di Giannuario, A., Pieretti, S., Catalani, A., Loizzo, A., 1999, Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats, Neurosci. Lett. 272:183–186.
Di Giannuario, A., and Pieretti, S., 2000, Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats, Peptides 21:1125–1130.
Dray, A., Davies, J., and Oakley, N.R., Tongroach, P., Vellucci, S., 1978, The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical and behavioural observations, Brain Research 151:431–442.
Gavioli, E.C., Marzola, G., Guerrini, R., Bertorelli, R., Zucchini, S., De Lima, T.C., Rae, G.A., Salvadori, S., Regoli, D., Calò, G., 2003, Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressantlike effects: pharmacological and genetic evidences from the mouse forced swimming test, Eur. J. Neurosci. 17:1987–1990.
Guerrini, R., Calò, G., Bigoni, R., Rizzi, A., Varani, K., Toth, G., Gessi, S., Hashiba, E., Hashimoto, Y., Lambert, D.G., Borea, P.A., Tomatis, R., Salvadori, S., Regoli, D., 2000, Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor, J. Med. Chem. 43:2805–2813.
Higgins, G.A., Jordan, C.C., and Skingle, M., 1991, Evidence that the unilateral actvation of 5-HT1D receptors in the substantia nigra of the guinea-pig elicits contralateral rotation, Br. J. Pharmacol. 102:305–310.
Higgins, G.A., Grottick, A.J., Ballard, T.M., Richards, J.G., Messer, J., Takeshima, H., Pauly-Evers, M., Jenck, F., Adam, G., and Wichmann, J., 2001, Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function, Neuropharmacology 41:97–107.
Hillegaart, V., Magnusson, O., and Ahlenius, S., 2000, A9 and A10 dopamine nuclei as a site of action for effects of 8-OH-DPAT on locomotion in the rat, Pharmacol. Biochem. Behav. 67:55–63.
Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R., and Humphrey, P.P.A., 1994, International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin), Pharmacol. Rev. 46:157–193.
Imai, H., Steindler, D.A., and Kitai, S.T., 1986, The organization of divergent axonal projections from the midbrain raphe nuclei in the rat, J. Comp. Neurol. 15:363–80.
Jacobs, B.L., and Fornal, C.A., 1997, Serotonin and motor activity. Curr. Opin. Neurobiol. 7:820–825.
Janssen P.A.J., 1983, 5-HT2 receptor blockade to study serotonin-induced pathology. TIPS 198–206.
Jenck, F., Wichmann, J., Dautzenberg, F.M., Moreau, J.L., Ouagazzal, A.M., Martin, J.R., Lundstrom, K., Cesura, A.M., Poli, S.M., Roever, S., Kolczewski, S., Adam, G., and Kilpatrick, G., 2000, A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat, Proc. Natl. Acad. Sci. USA. 97:4938–4943.
Koizumi, M., Midorikawa, N., Takeshima, H., and Murphy, N.P., 2004, Exogenous, but not endogenous nociceptin modulates mesolimbic dopamine release in mice, J. Neurochem. 89:257–263.
Kuzmin, A., Sandin, J., Terenius, L., and Ogren, S.O., 2004, Evidence in locomotion test for the functional heterogeneity of ORL-1 receptors, Br. J. Pharmacol. 141:132–140.
Lutfy, K., Do, T., and Maidment, N.T., 2001, Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats, Psychopharmacology (Berl) 154:1–7.
Maidment, N.T., Chen, Y., Tan, A.M., Murphy, N.P., and Leslie, F.M., 2002, Rat ventral midbrain dopamine neurons express the orphanin FQ/nociceptin receptor ORL-1, Neuroreport 13:1137–1140.
Marti, M., Guerrini, R., Beani, L., Bianchi, C., and Morari, M., 2002, Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat, Neuroscience 112:153–160.
Marti, M., Stocchi, S., Paganini, F., Mela, F., De Risi, C., Calò, G., Guerrini, R., Barnes, T.A., Lambert, D.G., Beani, L., Bianchi, C., and Morari, M., 2003, Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulatine 5-hidroxytryptamine and noradrenaline release in the rat neocortex, Br. J. Pharmacol 138:91–98.
Marti, M., Mela, F., Veronesi, C., Guerrini, R., Salvatori, S., Federici, M., Mercuri, N.B., Rizzi, A., Franchi, G., Beani, L., Bianchi, C., and Morari, M., 2004a, Blockade of nociceptin/orphanin FQ receptor signalling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behaviour, J. Neurosci. 24:6659–6666.
Marti, M., Mela, F., Trapella, C., Bianchi, C., and Morari, M., 2004b, Blockade of nociceptin/orphanin FQ transmission attenuates hypokinesia in hemiparkinsonian rats, Mov. Dis. 19(Suppl 9), P564.
Marti, M., Mela, F., Guerrini, R., Calò, G., Bianchi, C., and Morari, M., 2004c, Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release, J. Neurochem. 91:1501–1504.
Mela, F., Marti, M., Ulazzi, L., Vaccai, E., Zucchini, S., Trapella, C., Salvatori, S., Beani, L., Bianchi, C., and Morari, M., 2004, Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex, Eur. J. Neurosci. 19:1–8.
Meunier, J.C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.L., Guillemot, J.C., Ferrara, P., Monsarrat, B., Mazarguil, H., Vassart, G., Parmentier, M., and Costentin, J., 1995, Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor, Nature 377:532–535.
Mogil, J.S., and Pasternak, G.W., 2001, The molecular and behavioral pharmacology of the orphanin FQ/Nociceptin peptide and receptor family, Pharmacol. Rev. 53:381–415.
Murphy, N.P., and Maidment, N.T., 1999, Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis, J. Neurochem. 73:179–186.
Murphy, N.P., Lam, H.A., Chen, Z., Pintar, J.E., and Maidment, N.T., 2002, Heroin-induced locomotion and mesolimbic dopamine release is unchanged in mice lacking the ORL.1 receptor gene, Brain Res. 953:276–280.
Narayanan, K., Lam, H., Carroll, I., and Lutfy, K., 2004, OrphaninFQ/nociceptin suppresses motor activity through an action along the mesoaccumbens axis in rats, Rev. Psychiatr. 29:116–123.
Neal C.R. JR, Mansour, A., Reinscheid, R., Nothacker, H.P., Civelli, O., Akil, H., and Watson, S.J., JR., 1999, Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with 125I-[14Tyr]-orphanin FQ binding, J. Comp. Neurol. 412:563–605.
Nishi, M., Houtani, T., Noda, Y., Mamiya, T., Sato, K., Doi, T., Kuno, J., Takeshima, H., Nukada, T., Nabeshima, T., Yamashita, T., Noda, T., and Sugimoto, T., 1997, Unrestrained nociceptive response and dysregulation of hearing ability in mice lacking the nociceptin/orphaninFQ receptor, EMBO J. 16:1858–1864.
Noble, F., and Roques, B.P., 1997, Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in mice, FEBS Lett. 401:227–229.
Noda, Y., Mamiya, T., Nabeshima, T., Nishi, M., Higashioka, M., and Takeshima, H., 1998, Loss of antinociception induced by naloxone benzoylhydrazone in nociceptin receptor-knockout mice, J. Biol. Chem. 273:18047–18051.
Norton, C.S., Neal, C.R., Kumar, S., Akil, H., and Watson, S.J., 2002, Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems, J. Comp. Neurol. 444:358–368.
Oberlander, C., Hunt, P.F., Dumont, C., and Boissier, J.R., 1981, Dopamine independent rotational response to unilateral intranigral injection of serotonin, Life Sci. 28:2595–2601.
Okabe, C., and Murphy, N.P., 2004, Short-term of the nociceptin receptor antagonist Compound B on the development of methamphetamine sensitization in mice: a behavioural and c-fos expression mapping study, Brain Res. 1017:1:12.
Paxinos, G., and Watson, C., 1982, The Rat Brain in Stereotaxic Coordinates. Academic, Sydney.
Reinscheid, R.K., Nothacker, H.P., Bourson, A., Ardati, A., Henningsen, R.A., Bunzow, J.R., Grandy, D.K., Langen, H., Monsma, F.J. Jr, and Civelli, O., 1995, Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor, Science 270:792–794.
Rinvik, E., and Ottersen, O.P., 1993, Terminals of subthalamonigral fibres are enriched with glutamate-like immunoreactivity: an electron microscopy, immunogold analysis in the cat, J. Chem. Neuroanat. 6:19–30.
Rizzi, A., Bigoni, R., Marzola, G., Guerrini, R., Salvadori, S., Regoli, D., and Calo’, G., 2001, Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice, Naunyn Schmiedebergs Arch. Pharmacol. 363:161–165.
Robledo, P., and Feger, J., 1990, Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiologicol data, Brain Res. 518:47–54.
Sandin, J., Georgieva, J., Schott, P.A., Ogren, S.O., and Terenius, L., 1997, Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats, Eur. J. Neurosci. 9:194–197.
Sbrenna, S., Marti, M., Morari, M., Calo’, G., Guerrini, R., Beani, L., and Bianchi, C., 2000, Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin, Br. J. Pharmacol. 130:425–433.
Schlicker, E., and Morari, M., 2000, Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system, Peptides 21:1023–1029.
Slowe, S.J., Clarke, S., Lena, I., Goody, R.J., Lattanzi, R., Negri, L., Simonin, F., Matthes, H.W., Filliol, D., Kieffer, B.L., and Kitchen, I., 2001, Autoradiographic mapping of the opioid receptor-like 1 (ORL1) receptor in the brains of mu-, delta-or kappa-opioid receptor knockout mice, Neuroscience 106:469–480.
Starr, M.S., 1995, Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson’s disease, Synapse 19:264–293.
Stratford, T.R., Holahan, M.R., and Kelley, A.E., 1997, Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake, Neuroreport 8:423–426.
Tokuno, H., Morizumi, T., Kumo, M., and Nakamura, Y., 1988, A morphological evidence for monosynaptic projection from the nucleus peduncolopontinus pars compacta (TPC) to nigrostriatal projection neurons, Neurosci. Lett., 85:1–4.
Ueda, H., Inoue, M., Takeshima, H., and Iwasawa, Y., 2000, Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence, J. Neurosci. 20:7640–7647.
Vaughan, C.W., and Christie, M.J., 1996, Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones, Br. J. Pharmacol. 117:1609–1611.
Vaughan, C.W., Connor, M., Jennings, E.A., Marinelli, S., Allen, R.G., and Christie, M.J., 2001, Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro, J. Physiol. 534:849–859.
Walker, J.R., Spina, M., Terenius, L., and Koob, G.F., 1998, Nociceptin fails to affect heroin self-administration in the rat, Neuroreport 9:2243–2247.
Zheng, F., Grandy, D.K., and Johnson, S.W., 2002, Actions of orphanin FQ/nociceptin on rat ventral tegmental area neurons in vitro, Br. J. Pharmacol. 136:1065–1071.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this paper
Cite this paper
Marti, M., Manzalini, M., Bianchi, C., Heidbreder, C., Morari, M., Crespi, F. (2005). Nociceptin/Orphanin FQ Modulates Neurotransmitter Release in the Substantia Nigra: Biochemical and Behavioural Outcome. In: Bolam, J.P., Ingham, C.A., Magill, P.J. (eds) The Basal Ganglia VIII. Advances in Behavioral Biology, vol 56. Springer, Boston, MA. https://doi.org/10.1007/0-387-28066-9_17
Download citation
DOI: https://doi.org/10.1007/0-387-28066-9_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-28065-3
Online ISBN: 978-0-387-28066-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)